Duality Biotherapeutics, Inc. (HKG:9606)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
169.80
+1.20 (0.71%)
Oct 21, 2026, 3:59 PM HKT

Duality Biotherapeutics Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Net Income
-1,439-2,595-1,050-357.51-387.09
Depreciation & Amortization
13.8512.327.874.761.74
Other Amortization
---0.230.06
Asset Writedown & Restructuring Costs
--21.35--
Loss (Gain) From Sale of Investments
---1.16-
Stock-Based Compensation
108.81156.05190.4123.967.03
Other Operating Activities
31.332,311855.93903.9120.65
Change in Accounts Receivable
46.5569.39-276.77-120.97-0.75
Change in Accounts Payable
243.7586.52463.06154.4671.04
Change in Unearned Revenue
54.83-12.22112.21216.3-
Change in Other Net Operating Assets
120.5166.5-37.86-9.95-12.16
Operating Cash Flow
-818.88194.58285.78816.34-299.47
Operating Cash Flow Growth
--31.91%-64.99%--

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Capital Expenditures
-14.34-11.5-4.08-11.28-2.48
Sale (Purchase) of Intangibles
-2.36-2.22-27.1-24.62-19.72
Investment in Securities
-53.58-1,894-177.46--
Other Investing Activities
-22.17-4.55-2.51-42.65-
Investing Cash Flow
-92.45-1,913-211.15-78.55-22.2

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Short-Term Debt Issued
-141.06---
Long-Term Debt Issued
----135.19
Total Debt Issued
309.08141.06--135.19
Long-Term Debt Repaid
--4.43-3.4-138.69-1.43
Lease Payments
-4.55-4.43-3.4-3.5-1.43
Net Debt Issued (Repaid)
304.53136.62-3.4-138.69133.76
Issuance of Common Stock
14.011,757---
Other Financing Activities
-4.69-84.65-4.22-1.59-0.89
Financing Cash Flow
245.721,809-7.6210.82451.46

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Foreign Exchange Rate Adjustments
-63.08-23.3311.016.3118.42
Net Cash Flow
-728.6967.4978.02754.92148.21

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Free Cash Flow
-833.23183.08281.7805.05-301.95
Free Cash Flow Growth
--35.01%-65.01%--
Free Cash Flow Margin
-98.94%9.89%14.51%45.06%-18872.00%
Free Cash Flow Per Share
-9.322.8135.21100.63-37.74
Levered Free Cash Flow
-170.52-3,0371,0451,611-
Unlevered Free Cash Flow
-168.53-3,0371,0451,611-
Free Cash Flow After Leases
-837.77178.65278.31801.55-303.39

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash Interest Paid
2.981.210.250.190.08
Cash Income Tax Paid
--90.0554.54248.93-
Change in Working Capital
465.63310.19260.65239.8358.14